We have entered into a definitive agreement to sell our Infant Formula and Child Nutrition (IFCN) business in Greater China1 to Primavera Capital Group ('Primavera').

The outcome is the result of a comprehensive strategic review and is in line with our strategy to actively manage our portfolio as part of our plan to rejuvenate sustainable growth.

1 China, Hong Kong and Taiwan

Attachments

  • Original document
  • Permalink

Disclaimer

Reckitt Benckiser Group plc published this content on 05 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 June 2021 16:40:01 UTC.